<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>29</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title> Neuroprotective effect of silibinin linked with attenuated Interleukin-6 and TNFα in an Aβ1-40 Induced Alzheimer’s rat model</title>
	<subject_fa>Neurophysiology/Pharmacology</subject_fa>
	<subject>Neurophysiology/Pharmacology</subject>
	<content_type_fa>Short communication</content_type_fa>
	<content_type>Short communication</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Arial;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; The mechanisms behind Alzheimer&amp;rsquo;s disease (AD) remain largely unclear. Reactive oxygen species and inflammatory cytokines contribute to inflammation and synaptic dysfunction in AD. This study investigates whether silibinin&amp;rsquo;s neuroprotective properties act through regulating oxidative stress and inflammation.&lt;br /&gt;
&lt;strong&gt;Methods: &lt;/strong&gt;Forty-eight Wistar rats (230&amp;plusmn;20g) were divided into four groups. The control group comprised healthy animals, while the lesion group received amyloid beta (A&amp;beta; 1-40 ). The vehicle group received silibinin solvent post-A&amp;beta;1-40 injection. Treatment groups received silibinin (50, 100, and 200 mg/kg) after A&amp;beta;1-40 injection. Following a passive avoidance behavior test, biochemical analysis of superoxide dismutase (SOD), malondialdehyde, Tumor necrosis factor &amp;alpha; (TNF -&amp;alpha;) and interleukin-6 (IL-6) was conducted.&lt;br /&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Administration of 100 mg/kg silibinin significantly reduced serum IL-6 levels compared to the lesion group (P=0.005). All silibinin doses significantly decreased TNF-&amp;alpha; levels (P&amp;le;0.001). Serum superoxide dismutase (SOD) levels increased significantly in animals treated with 100 and 200 mg/kg silibinin compared to the lesion group (P=0.002, P=0.03). Step-through latency improved in silibinin-treated animals (100 and 200 mg/kg) (P&amp;le;0.006).&lt;br /&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;These results suggest silibinin can enhance cognitive function and offer neuroprotection by inhibiting lipid peroxidation and reducing pro-inflammatory cytokines (TNF-&amp;alpha; and IL-6) in AD rat models.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Alzheimer’s disease, Neuroinflammation, Silibinin, Oxidative stress</keyword>
	<start_page>232</start_page>
	<end_page>239</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-2313-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sajjad</first_name>
	<middle_name></middle_name>
	<last_name>Salari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sajjad.salari@medilam.ac.ir</email>
	<code>3200319475328460038038</code>
	<orcid>0000000168922544</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Physiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Monireh</first_name>
	<middle_name></middle_name>
	<last_name>Azizi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>azizi-m@medilam.ac.ir</email>
	<code>3200319475328460038039</code>
	<orcid>000000033090867X</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Anatomy, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Tahereh</first_name>
	<middle_name></middle_name>
	<last_name>Alihosseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>t.a.h.radiology@gmail.com</email>
	<code>3200319475328460038040</code>
	<orcid>3200319475328460038040</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Anatomy, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Bagheri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maryam.bagheri@medilam.ac.ir</email>
	<code>3200319475328460038041</code>
	<orcid>3200319475328460038041</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Physiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
